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Abstract: Glucose transporters (GLUT) are twelve-transmembrane spanning proteins that contain two pores capable of 
transporting glucose and dehydroascorbate in and out of cells. The mechanism by which transport is effected is unknown. 
An evolutionarily-based hypothesis for the mechanism of glucose transport is presented here based on reports that insulin 
has multiple binding sites for glucose. It is proposed that insulin-like peptides were incorporated as modular elements into 
transmembrane proteins during evolution, resulting in glucose transporting capacity. Homology searching reveals that all 
GLUT contain multiple copies of insulin-like regions. These regions map onto a model of GLUT in positions that deﬁ  ne 
the glucose transport cores. This observation provides a mechanism for glucose transport involving the diffusion of glucose 
from one insulin-like glucose-binding region to another. It also suggests a mechanism by which glucose disregulation may 
occur in both type 1 and type 2 diabetes: insulin rapidly self-glycates under hyperglycemic conditions. Insulin-like regions 
of GLUT may also self-glycate rapidly, thereby interfering with transport of glucose into cells and disabling GLUT sensing 
of blood glucose levels. All aspects of the hypothesis are experimentally testable.
Introduction
Root-Bernstein and Dillon have suggested that molecular complementarity acts as a selective pres-
sure that directs evolution in particular directions by linking molecular structure and function. In 
essence, those molecules that bind to one another are more likely to survive degradative processes 
and so become the materials upon which living systems build. Further, the complexes that such pairs 
of molecules will form will have emergent properties that their individual components do not, thereby 
providing a constant source of novelty upon which further complexity can be built. (Root-Bernstein 
and Dillon, 1997; Hunding et al. 2006) Root-Bernstein recently applied this theory to the elucidation 
of insulin receptor evolution. Insulin both self-aggregates and binds to glucagon, making insulin 
self-complementary and complementary to glucagon. (Root-Bernstein and Dobblestein, 1999) Nota-
bly, the insulin receptor has multiple insulin-like and glucagon-like sequences located in regions 
associated with insulin binding, and these regions are highly conserved throughout evolution (Root-
Bernstein, 2004; Root-Bernstein, 2005).
Another interesting aspect of insulin behavior is that glucose binds directly to it, suggesting that 
glucose and insulin were linked functionally very early in evolution. Various physicochemical methods 
(Anzenbacher and Kalous, 1975; Kalous and Anzenbacher, 1979), x-ray crystallography (Yu and Caspar, 
1998), and molecular modeling programs (Zoete, Meuwly and Karplus, 2004) have demonstrated that 
eight D-glucose binding sites exist on the insulin molecule, two with a binding constant of about 
1 × 10
–3 M and six with a binding constant of about 6 × 10
–2 M. This means that at normal blood glucose 
of 5 × 10
–3 M, the two higher afﬁ  nity sites are likely to be occupied, while the lower afﬁ  nity sites are 
likely to be sensitive only to hyperglycemic conditions. One can hypothesize that prior to the origins 
of insulin receptors and glucose transport proteins, an insulin-like molecule may have carried glucose 
into cells itself. In addition, in the presence of glucose, insulin is rapidly and non-enzymatically glycated, 
which may have a variety of effects to be discussed below.
The binding of glucose to insulin, combined with the molecular complementarity theory of evolu-
tion, suggested that perhaps glucose transporters (GLUT) might have evolved from an insulin-like 
precursor that could also bind glucose. If that were the case, then one would expect to ﬁ  nd modular 
insulin-like regions in the transporter core of GLUT but not at the transporter cores of other sugar 
transporters. This paper reports that this prediction is correct. It describes how such a structure results 318
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in functional glucose transport and how glycation 
of the insulin-like regions in GLUT might result 
in insulin resistance and inability to transport 
glucose efﬁ  ciently.
Methods
Sequence similarities were determined between 
the human insulin precursor (SwissProt ID P01308) 
and all human GLUT precursor sequences avail-
able on the SWISSPROT database as of November 
2006 (GTR1 P11166; GTR2 P11168; GTR3 11169; 
GTR4 P14672; GTR5 P22732; GTR6 Q9UGQ3; 
GTR8 Q9NY64; GTR9 Q9NRM0; GTR10 
O95528; GTR11 Q9BYW1; GTR14 Q8TDB8). A 
further set of similarity searches was carried out 
in November 2006 involving the sodium/glucose 
cotransporters 1, 2 and 3 (P13866, P31639, and 
Q9NY91), using as control sequences the sodium 
dependent phosphate transporter proteins 1, 2A, 
2B, 2C, 3, and 4 (Q14916, Q06495, O95436, 
Q8N130, O00624, O00476), the sodium dependent 
phosphate transporter 1 (Q8WUM9), the yeast 
mannose transporter (P40107), and the arabidopsis 
mannose transporter (Q941R4).
Similarities were determined using LALIGN 
(Huang and Miller, 1991). The best 20 similarities 
were found using default parameters for scoring 
(penalty for the ﬁ  rst residue in a gap, −14; penalty 
for each additional residue in a gap, −4). Sequences 
were deemed to be signiﬁ  cantly homologous only 
if they had at least ﬁ  fty percent identity over a 
sequence of at least ten amino acids or a raw score 
(E) of at least 35. Ten amino acid-long sequences 
were chosen because ten amino acid stretches are 
approximately the length recognized by T-cell 
receptors and are therefore of some biological 
signiﬁ  cance (Rudensky et al. 1991) and because 
in previous studies, it was determined using 
LALIGN that the probability of a hormone such 
as insulin or glucagon having ﬁ  ve identical amino 
acids within any stretch of ten amino acids in ran-
domly selected receptors or transporters is six 
percent (p = 0.06) (Root-Bernstein, 2002). 
A secondary estimation of the signiﬁ  cance of the 
similarities was also used, involving raw scores. 
Raw scores (E) are used by LALIGN to derive a 
function that calculates the probability that an 
alignment with such a score is likely to occur if 
any peptide of an equivalent length were used to 
search 10,000 proteins of equivalent length to the 
receptor or transporter sequence. Raw scores of 35 
or above in this study always corresponded to 
probabilities of less than 1 in 20 that such align-
ments occur by chance (p  0.05). Raw scores 
above 50 generally corresponded to probabilities 
of less than 1 in 100 that such alignments occur by 
chance (p  0.01). The vast majority of the 
sequences described in the tables below satisfy 
both sets of criteria for signiﬁ  cance.
It must be emphasized that the probabilities 
presented above correspond to that of ﬁ  nding a 
single homology between a peptide hormone and 
a receptor satisfying one or the other criteria. The 
probability that more than one such signiﬁ  cant 
homology would occur within a single receptor or 
transporter is a multiplicative function of the num-
ber of signiﬁ  cant sequences found. The probability 
of ﬁ  nding four such similarities within a single 
transporter sequence is approximately (0.05)
4 or 
about 6 × 10
–6 and the probability of ﬁ  nding seven 
such signiﬁ  cant similarities is about 10
–11. All of 
the GLUT transporters have between four and 
twelve signiﬁ  cant homologies so that the probabil-
ity that the results presented here have occurred by 
chance are extremely small.
The sequences of GLUT transporters that had 
high homology with insulin were mapped onto the 
model of the GLUT transporter developed by 
Zuniga et al. (Zuniga et al. 2001) using the amino 
acid identiﬁ  ers in their model.
Results
The results of the homology study are displayed in 
Tables 1 through 14. As can be seen by inspection, 
every human GLUT sequence currently available 
on SwissProt has multiple homologies with insulin 
satisfying the criteria described above (Tables 1–11). 
Particularly notable are GLUT 1, GLUT 4, GLUT 6, 
GLUT 10, and GLUT 11. GLUT 1 has eight sig-
niﬁ  cant homologies; GLUT 4 has ten; GLUT 6 and 
10 have seven, and GLUT 11 has eleven. Most 
strikingly, GLUT 11 has one homology that repre-
sents virtually the entire unprocessed insulin chain. 
Many significant similarities were also found 
between the sodium/glucose cotransporter proteins 
and insulin (Tables 12–14).
No signiﬁ  cant similarities at all were found 
between insulin and the sodium dependent phos-
phate transport proteins, the sodium dependent 
phosphate transporter, or mannose transporters 
(data not shown, since there is nothing to show). 
These results are in accord with our previous 319
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observation that insulin-like regions are extremely 
rare in randomly selected receptors and enzymes 
(Root-Bernstein, 2002) It is also interesting to note 
that mannose transporters lack signiﬁ  cant homol-
ogies to the QLSQQLS, and QLG sequences that 
have been identiﬁ  ed through amino acid substitu-
tion and modeling as probable glucose recognition 
regions in GLUT (Seatter et al. 1998; Olsowski 
et al. 2000, Salas-Burgos, 2004).
On the other hand, insulin itself contains several 
regions that have the QLS and QLG motifs associ-
ated with insulin binding—although these are 
sometimes in the reversed order—and these motifs 
occur in regions with signiﬁ  cant homologies to 
GLUT transport cores (see underlines in Tables 
1–11). Thus, the insulin-like homologies reported 
here correspond to putative glucose binding regions 
identified by previous investigators of GLUT 
structure (Seatter et al. 1998; Olsowski et al. 2000, 
Salas-Burgos, 2004; Hruz and Mueckler, 2001; 
Zuniga et al. 2001).
In order to demonstrate the location of these 
insulin-like regions in the GLUT structure, the 
homologies listed in Tables 1–11 (the GLUT 
sequences) have been mapped onto Zuniga et al.’s 
model of GLUT transport cores (Zuniga et al. 2001). 
INS 81–87        ALE GSLQ
                                                  | :    |  |  |  |
GLUT 1  17–25    GGAVLGSLQ 34E 
 | |          |  |  |  |
INS 70–78    GGPGAGSLQ
GLUT 1 56–93                 I LPT–T LTTL W SLS – VA I FSVGG M IGSFSVGLFV NRFGRR
               : | |       : |     : |  |   :     :      : | : |   /           :    | |  :    |       : :            |    |
INSULIN 7–46                LLPLLALLALWGPDPAAAFV NQH LCGSHLVEALYLVCG ER 
INS 84–92                                GS LQKRGIV
                          | :  |  : :      | | |
GLUT 1  137–165   TGFVPMYVGEVSPTAFRGALGTLHQLGIV 37E
              :     |  | :  :  : |     | :     | : |  
INS 67–86                 REAEDLQVGSLQPLALEGSL 
GLUT 1  181–190  GNKDLWPLLL     27E
 |        :  |    |  |    | 
INS 73–82    GAGS LQPLAL 
GLUT 1  278–286              LQLSQ – QLSG     21E 
                                            | | :  :  |     : |  :  | 
INS 61–70                          LQVGQVELGG 
GLUT 1 310–329               AT I GSGIVNTAFT–VVSLFVVE     26E  
                               / /         | | | :  :       |   :    | | :     :  |
INS 90–1XX                       SL QKRGIVEQCCTSICSLYQLE
GLUT 1  353–394  WMSYLSIVAIF GFVAFFEV GPGPI PWF IVA EL 38E
 |   |       |    : :  | : :  :  :                  |  |    |          | :        : |   
INS 4–30  WMRLLPLLALLALW – – – – –GPDPAAAF VNQHL 
GLUT 1  390–406  IVAELFAQ GPRPAAIA V 40E
: :  |   |            | |    |   |  |       |
INS 10–26  LLALLALWGPDPAAAFV 
GLUT 1  449–471  YFKVPETKGRTFDEI ASGF RQGG  36E
:  |     : |  : |  :     : :    |       :  :       :     | |
INS 48–70  FFY TPKTRREAEDLQVGQVELGG 
Table 1. GLUT 1-Insulin similarities.320
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Table 2. GLUT 2-Insulin similarities.
 
Table 3. GLUT 3-Insulin similarities.
 
GLUT 2  176–188  GEIA PTALRGAL 41E
 |   :     |    |  | :   |  : |
INS 75–86    GSLQPLALE GSL
GLUT 2   217–230  LWHI  LLGLSGVRAI         30E
|  |         | |     |     : :     | :
INS 3–16    LWMRLLP LLALLAL
GLUT 2  174–196   MYIGE IAPTALR GALGTFHQLAI       28E 
:     : | :  :          :        | |      |  : :  :    |   |: 
INS 61–82     LQVGQVELGGGPGA– GSLQPLAL
GLUT 2  406–417  LFVSFF E I GPG P 33E
|     | :        | :   |    |  |
INS 61–72    LQVGQVELGGGP 
GLUT 2  430–435  GPRPAA  36E
 | |    |   |  |
INS  18–23    GPDPAA 
To simplify the visualization of the placement of 
the various homologies, only those shared by 
GLUT 1 and GLUT 4 (arguably two of the most 
important of the GLUTs) were used; these were 
reformatted (Table 15) to display their common-
alities; and these common areas were then mapped 
onto Zuniga’s model of the transport cores by 
means of color coded dots (Figure 1). Figure 1 
demonstrates that many of the insulin-like regions 
that are common among the GLUTs can be 
assigned to regions of the GLUTs thought to deﬁ  ne 
the transporter core itself. Notably, these insulin-
like regions are found to be in the transporter cores 
of all models of GLUT (e.g. Seatter et al. 1998; 
Olsowski et al. 2000, Salas-Burgos, 2004; Hruz 
and Mueckler, 2001). Moreover, all of the amino 
GLUT 3 61–118  SLWSLS VAI FSVGGM I GSFSVGLFVNRFGRRNSMLI VNLLAVTGG–C FMGLCKVAKSVEM       43E
:  |  |           |    : :  : :     : :      |         :  :    |  |  | :            :  |     |  :      |        |     |          |  :           | :    :     :  | 
INS 2–61  ALWMRLLPLLALLALWGPDPAAAFVNQH–LCGSH LVEALYLVCGERGFFYTP KTRREAE  D
GLUT 3 143–154   GE ISPTALRGAF  38E
 |    ::  |    |  |  :  |  : : 
INS 75–86    GSLQPLALEGSL 
GLUT 3  155–163  GTLNQLGIV  32E 
 |  : |  :  :    | | |  
INS 84–92    GSLQKRGIV 
GLUT 3 380–406               GPGPIPW FIVA ELF  SQ GPRPAAMAVAG  36E 
|  |     |          | :       : |      : :            |    :      |     |  
INS 18–43    GPDPAAAFVNQHLCGSH LVEALYL VCG  
GLUT 3 388–404   IVAELFS Q GPRPAAMAV  40E 
: :  |    |            | |    |  |  |       | 
INS 10–26    LLALLALWGPDPAAAFV 
GLUT 3 447–461   FFKVPETRGRTFEDI  42E
      |  |     : | :  | |     |       |  | : 
INS 48–61    FFYTPKTR– REAEDL 321
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Table 4. GLUT 4-Insulin similarities.
acids thus far identiﬁ  ed as contributing to glucose 
recognition and binding through mutagenesis 
studies fall into these insulin-like regions or imme-
diately adjacent to them, including GLUT 1 resi-
dues W65, S66, T137, V140, QLS 161–163, V165, 
QLS 279–285, T310, N317, T321, R333, P387, 
and W388 (Seatter et al. 1998; Olsowski et al. 
2000, Salas-Burgos, 2004; Hruz and Mueckler, 
2001; Zuniga et al. 2001).
These data therefore show that the transport 
cores of GLUT, as deﬁ  ned by current experimental 
and modeling data, are composed of repeating 
GLUT 4   31–37  AVLGSLQ 28E
 |  :    |  | |  |
INS 81–87    ALEGSLQ
INSULIN 7–46                LLPLLALLALWGPDPAAAFV NQH LCGSHLVEALYLVCG ER 
                                            :  |       : |      : |  |  :    :     :  | :  |    \          :        |  : | :     : :            |     :
GLUT 4  90–109                 IPPG– TLTTL WALS – VA I FSVGG M I SSF L IG I ISQWLGRK
GLUT 4  124–147  SLMGLANAAASYEML ILGRFL IGA  30E
: |       |         |  |  |       :  :     :   |       |  :    |
INS 15–38    ALWGPDPAAAFVNQHLCGSHLVEA 
GLUT 4   158–180  MYVGE IAPTHLRGALGTLNQLAI 30E
:      |  | :  :                  | |    |   : |  :    |   | :  
INS 61–82    LQ VGQVELGGGPGA–GS LQPLAL
INS 2–16          ALWMRLLPLLALLAL
                                                    :  |  |        | |     |     : |    |  |
GLUT 4  197–214  GTASLWPLLL G LTVLPAL       38E 
 |  :  :  | |     | |    |
INS 73–82    GAGSLQPLAL 
GLUT 4  204–238  LL LG LTVLPALLQV – LLP FCPESPRYLY I IQNLEG  35E
:    |       :     : | |     |      :     |       :     | :   |          : :     | :  |  : |  
INS 1–32  MALWMRLLPLLALLAL—WGPD–PAAAFVNQHLCG
GLUT 4 273–286                LSLLQL LGSR THR    28E
                                             | :    |     |     |  |    : :  |
INSULIN 79–92                  LQPLALEGSLQ KR             
GLUT 4  294–302              LQLSQ – QLSG      21E 
                                            | | :  :  |     : |  :  | 
INS 61–70                          LQVGQV ELGG 
GLUT 4 307–330  FYYSTS I FETAGVGQPA YATIGAG       33E
| : |  :              \  |  :       |     :     : : :  |  : |
INSULIN 47–71  FFYTPKTRREAEDLQVGQVELGGG    
GLUT 4  350–362  RTLHLLGLAGMC G        28E 
 |    |    |  |   :|     :  :      |
INS 6–18  RLLP LLALLA LWG 
INS 18–44    GPDPAAAFVNQHLCGSHLVEALY LVCG 
                                            |  |    |           | :        : |     : :            |     :     |     |
GLUT 4  398–424  GPGP I PWF IVAEL F SQGPRPAAMAVAG  40E
                       : :  |    |           | |     |  |  |        |
INS 10–26                        LLALLALWGPDPAAAFV322
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subunits, or modules, based on an insulin-like 
sequence. It is further reasonable to propose that 
since insulin has multiple binding sites for glucose, 
these insulin-like modular regions are the basis for 
GLUT binding and transport of glucose.
Discussion
The fact that glucose binds to insulin and that 
insulin-like regions make up the transport cores of 
GLUT proteins suggests an obvious mechanism 
by which glucose can be transported through these 
proteins. Glucose would be attracted from extracel-
lular plasma to the glucose-binding sites on the 
insulin-like regions in the transport core. Simple 
diffusion from one site to another within the trans-
port core would carry the glucose from the extra-
cellular to the intracellular side of the transporter 
as long as the concentration of glucose was higher 
outside the cell than inside. Because the proposed 
Table 5. GLUT 5-Insulin similarities.
Table 6. GLUT 6-Insulin similarities.
GLUT 5  12–22    RLTLVLALATL               26E 
 |  |      : |  | |      : | 
INS 6–16    RLLPLLALL AL
GLUT 5  85–100   GSLLVGPLVNKFGRKG   30E 
 |  |    |  |       |            |  : :  | 
INS 32–47    GSHLVEALYLVCGERG 
GLUT 5  151–172  GELAPKNLRGAL – – –GVVPQL F I TV  38E 
        |    |    |       | :   |  : |          |  :  |     |         : :   
INS 75–99    GSLQPLALEG SLQKRGI VE QCCTSI 
GLUT 5  214–223  ALQ LL LLPFF          31E 
 | |      :     | |  |  : :     
INS 2–11    ALWMRLLPLL 
GLUT 6  91–109   GAAAGGLSAMILNDLLGRK 36E
|     :  |  |  :  | :     :    | :       |     : :  
INS 71–89    GPGAGS LQPLALEGSLQKR
GLUT 6  167–182  GALGATPQLMAVFGSL  28E
 |       : :  :     |    :  |  :    |  | |
INS 71–86    GPGAGS LQPLALEG SL 
GLUT 6  278–288  VAL L MRLLQQL
 :  | |       |  |  |  |      |
INS 1–11    MALWMRLLPL L 
GLUT 6  308–66     LLP PKDDAAI VGAVRLLSVLIA ALTMDLAGRKVLLFVSAAIMFAANLTLGLYI HFGPRP     38E 
                  |       |           |  | :  |  :               |     |  :    : :     :     :    | :  :     : : :  :       :         |    : |     :  |    :  :  : |      |
INS 16–72               LWGPDPAAAFVNQHLCGSHLVEALY L– VCGERGFFYTPKTRREAEDLQVG–QVELGGGP 
INS 2–14    ALWMRLLPLLAL L
|     :  :    |  :  |  | |   |    :
GLUT 391–403    AGYLTLV PLLATMLFIMGYAVG WGP           38E 
        |          :  |   : :   :       :      |  | |
INS 3–19         LWMRLLPLLAL LALWGP
GLUT 6  481–497  CCVPETKGRSLEQIES F  29E
 |  |         |  :        | |     | : |  :  :
INS 92–108  CC– – – TSIC  SLYQLE NY323
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mechanism is passive, diffusion could also occur 
from the inside of the cell out if the concentration 
of glucose were higher within the cell than outside 
it. If the binding afﬁ  nities were essentially equal 
from one site within the transport core to the next, 
then transport would occur with equal velocity in 
either direction. If the bindings progress either 
toward greater afﬁ  nity from outside in, or vice 
versa, then the velocity of diffusion will differ 
depending on whether the glucose is diffusing into 
or out of the cell. The difference in rate will depend 
on the difference in afﬁ  nities across the transporter. 
Differential afﬁ  nities might be of value in regulat-
ing rates of glucose ﬂ  ow.
The fact that multiple insulin-like regions occur 
within the transport core should not come as a great 
surprise in terms of the way in which most proteins 
are thought to have evolved. An ever-increasing 
body of literature suggests that large proteins are 
often conglomerates of repeating subunits or mod-
ules (e.g. Patthy, 1999; Liu and Rost, 2004; Born-
berg-Bauer et al. 2005). Thus, the structure 
proposed here for GLUT proteins may be seen as 
just one of many known modular protein structures. 
Table 7. GLUT 8-Insulin similarities.
Table 8. GLUT 9-Insulin similarities.
GLUT 8  24–37  RRVFLAAFAAAL GP  27E
|     :    |     |  :    |        | |     
INS 6–19  RLLP LLALLALWGP 
GLUT 8  122–133  MLLGG  RLLTGLA 26E 
|     |          |  |  |       |  |
INS 1–12    MALWMRLLPL LA
GLUT 8  170–177  LLAYLAGW 35E
| |  |    |   |     |
INS 10–17  LLALLALW
INS 6–20  RLLP LL ALLALWGPD
  |          :     |  |      |   |   |    :
GLUT 8  194–236  LMLLLMCFMPETPRF LLTQ H RRQEAMAALRFLWGSEQGWEDPP 42E
|  :     | |        |     |  :            : :  :  |  |                 :  :   \ \    : |         : |  :  |  :        |
INS 10–52  LLALLAL WGPDPAAAFVNQH C G SH LVEAL YLVCGERG F FYTP 
GLUT 8  345–351  GGPGNSS  38E
 |  |  |  |    :  | 
INS 70–76    GGPGAGS 
GLUT 9  156–166  ACS LQAGAFEM  29E 
|     :  |  |  :  |       |  :  
INS 58–68    AE DLQVGQVEL
GLUT 9  299–308  I  RLVSVLELL          29E 
:  |  |  :   :  |    |  | 
INS 5–15    MRLLPLLALL 
GLUT 9  310–339  APYVRWQVVTVIVTMACYQLCGLNAIWFYT     38E 
|     :  |        :  :           :  :     |     |    : |   |       :   :  |  |  |   
INS 23–51    AAFVNQ HLCGSHLVEAL YLVCGERG–F FYT 
GLUT 9  321–340  IVTMACYQLCGLNAIWFYTN      45E 
| |     :     |     : :  |  : :      :        |    | 
INS 91–110    IVE QCCT SIC SLYQLENYCN 324
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What is unusual about this example of modularity 
is that it may have been based on complementarity 
between a pair of simple molecules (insulin and 
glucose) that dictated selection for the speciﬁ  c 
utility and function of the modules during the 
evolutionary process itself (Root-Bernstein and 
Dillon, 1997). Since this is also the case in the 
insulin receptor, one may speculate that such 
complementarity will be found in other receptor 
and transporter proteins as well.
The hypothesis that GLUT evolved from the 
stringing together of insulin-like modules capable of 
binding glucose makes a number of novel, experi-
mentally testable predictions. Synthetic peptides 
derived from the regions of insulin-like homology 
listed in the Tables above should bind glucose with 
approximately the affinity previously found for 
insulin-glucose binding sites. For reasons described 
above regarding the rate of ﬂ  ow of glucose through 
the transporter, it will be interesting and important 
to determine whether all of the binding sites are more 
or less similar in their glucose afﬁ  nity, or whether 
they increase in one direction or the other.
A second prediction of the hypothesis is that 
these insulin-like regions of GLUT should glycate 
rapidly (hours to days) in hyperglycemic condi-
tions. It has been shown by several groups of 
investigators that insulin in the presence of either 
unusually high concentrations of glucose, or nor-
mal glucose concentrations for longer periods of 
time, will auto-glycate. (Farah et al. 2005; 
McKillop et al. 2003; Abdel-Wahab et al. 2002; 
Boyd et al. 2000; O’Harte et al. 2000; Abdel, 
Wahab et al. 1997a, b; O’Harte et al. 1996; Doll-
hofer and Wieland, 1979). This auto-glycation 
occurs on both N- and O-groups of amino acids; 
is non-enzymatic; and its effect on insulin is to 
decrease its activity. In contrast to the very slow 
(weeks to months) non-enzymatic glycation of 
most proteins (Schalkwijk, Stehouwer and van 
Hinsbergh, 2004; Vlassara and Palace, 2002; 
Baynes, 2001), the glycation of insulin is very fast, 
beginning within hours and reaching a maximum 
within 24 to 36 hours in hyperglycemic conditions. 
(Farah et al. 2005; McKillop et al. 2003; Abdel-
Wahab et al. 2002; Boyd et al. 2000; O’Harte et al. 
2000; Abdel, Wahab et al. 1997a, b; O’Harte et al. 
1996; Dollhofer and Wieland, 1979) One would 
expect the same rapid glycation to occur on the 
insulin-like regions of GLUT. This prediction can 
Table 9. GLUT 10-Insulin similarities.
GLUT 10   7–18  VLPLCASVSLL G         34E 
:  |  |  |    |    :  : |      |
INS 7–18    L LPLLALLALWG
GLUT 10  30–42  SGALLPLQLDFGL  35E
:  |  : |     |  |    |  :    : |  
INS 74–86    AGSLQP LALEGSL
|  |  |  |       |  :  |    |  | |
GLUT 10 87–99                AGSLT– LGLAGSL 35E
GLUT 10  50–78  LVGSLLLGAL – LASLVGGFLIDCYGRKQA  34E
|     |  |    | :     | |     |  :            | |  :              |  :  :  |
INS 30–58  LCGSHLVEALYLVCGERGFFYTPKTRREA 
GLUT 10  76–84   QAI LGSNLV  29E
|     :    |  |  : |  |  
INS 28–36  QHLCGSHLV 
GLUT 10  271–304  LASVGLGAVKVAATLTAMGLVDRAGRRALLLAGC 35E
: :  :  |     | |              |  :  : |        :  :  |               :  |  : : :        |
INS 63–96    VGQVELGGGPGAG SLQP LALEGSLQ KRGIVEQCC
GLUT 10 337–368  GQTGLP GDSGLLQD SSLP PIPRT NEDQREP IL  30E 
|   | :     |     |        |            :  | |     | :         :       |  : :    | :
INS 64–92    GQVE LGGGPGA – – – GSLQPLALEGSLQKRGIV 325
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be tested both in vitro using insulin-like peptide 
regions derived from GLUT, or under in vivo con-
ditions, in which the GLUT are isolated and ana-
lyzed for the presence of glycation products within 
speciﬁ  c regions of the transport core. If glycation 
is present under in vivo conditions, it would further 
be predicted that glucose transport would decrease 
inversely to increasing GLUT glycation.
A third test of the hypothesis stems from the 
fact that GLUT also transport dehydroascorbate 
(DHA) (reviewed in Root-Bernstein, Busik and 
Henry, 2002). It can be predicted, therefore, that 
insulin and the insulin-like regions of GLUT 
should bind DHA with affinities approximating 
those which they bind glucose. Moreover, DHA 
binding may significantly retard glycation, 
which can be tested in both the in vitro and 
in vivo conditions just specified above. This 
prediction may be of clinical significance as 
well (see below).
Table 10. GLUT 11-Insulin similarities.
GLUT 11 64–158   LLMWSL IVS LYPLGGL F GALLAGPLAITLGRKKSLLVNNI FVVSAA IL FGFSRKAGS 
:     :  |        : :     |      |      : |  :   |         |  :    :    : :                |   |  |  :    : :  :  |     :         |    :  :   |  :
INS 1–92    MALWMRLLPLLALLALWGPDPAAAF–VNQHLCGSHLVEALYLVCGERGFFYTPKTRR 
F –EMIMLGRLLVGV NAGVSMNIQPMYLSESAPKELRGAV       52E 
     |    : :  :   | :  :    :  |      :     | :  :     ::  |  |  :    |           |   |       |  | :  |
EAEDLQVGQVELGGGP GAG– SLQPLA LEGSLQK – –RGI V 
GLUT 11  70–76  IVSLYPL 26E
|    | |  |    |
INS  99–105  ICSLYQL
GLUT 11  72–83  SLYPLGG LF GAL 26E
| |     | |  :      |      | : |
INS 76–86  SLQPLA – LE GSL 
GLUT 11 69–100   L I VS LYPLGGL F GALLAGPLAITL GRKKSLLV      42E
|     |  :          |   |  |        |  |            |  |  | :       :    :  |       : |
INS 61–92    LQVGQVE LGGGP GAGSLQPLALEGSLQKRGIV 
      |  |        | |      | |  |      |        |
GLUT 11 176–190       VGLRELL GGP QAWPL     45E 
GLUT 11  198–226           PGALQLASLPLLPESP RYLL I DCGDTEAC  33E 
         |  |  |     : |       |    |              :       :  : :           |      |
INS 69–100    GGGPGAGSLQPLALEGSLQKRGIVEQCC TSI C
|  :  |       |  |    |   :   |       |
GLUT 11  235–249  GSGDLAGEL EELEEE  36E
GLUT 11 286–294  LCGNDSVYA  31E
|  |  |  :       |     |
INS 30–38  LCGSHLVE A
GLUT 11  383–397  FGI GP– AGVTGILATE 29E
:  |    | |      |  |            |  |    |   
INS 68–83    LGGGPGAGSLQPLALE
GLUT 11  386–412  GPAGVTGI LATELFDQMARPAACMVCG 37E
 | |        :  :  : : :        : |       :             |      :  |  |  |
INS 18–44    GPDPAAAFVNQHLCGSHLVEALY LVCG 
GLUT 11  446–460  VCGAIYT GLFL –PETK  27E
|  |  |             | : |       |  :  | : 
INS 42–55    VCGE – –RGFFYT PKTR 326
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Table 12. Na+/Glucose high afﬁ  nity co transporter 1/Insulin similarities.
Table 11. GLUT 14-Insulin similarities.
GLUT 14  9–30   VSG IGGFLVSLTSRMKPHTLAV  33E
|    |       |  | :  :  :      :  |    :     :   |     |
INS 42–63  VCGERGFFYTPKTRREAEDLQV 
GLUT 14  167–178  GEI SPTALRGAF  38E
|    : : |     |  | :  |  : :
INS 75–86    GSLQPLALEGSL 
GLUT 14  398–407  VACFE I GPGP  33E
| :        |  :  | :  | | 
INS 63–72    VGQVELGGGP 
INS 10–26                       LLALLALWGPDPAAAFV
                      : :  |    |          |  |    |  |  |       |
GLUT 14  404–430  GPGP I PWFI VAELFSQGPRPAAM AVAG  40E
| |    |           | :          |     : :            |     :    |      |
INS 18–44    GPDPAAAFVNQHLCGSHLVEALYLVCG
GLUT 14  471–485     FFKVPETRGRTFEDI  42E
      |  |     : |  : |  |    |       |  | | 
INS 48–61  FFYTPKTR—REAEDL 
SLC5A1 597–610     KKKGIFRRAYDLFCGLEQ           39E 
:  |  :  | |   : :             :   | : |     |
INS 87–105  QKRGIVEQCCTS I CSLYQL
                                                                    |    |   | |     : :    |
SC5A1  517–527                          CPTIICGVHYL       36E 
SLC5A1  175–191  LNL Y L A I FLLLAI TALY           37E
:     |  :  :      : :    | |  |  :    |  |  :
INS 1–17    MALWMRLLPLLALLALW 
SLC5A1 276–318   WPGF IFGMS ILTLWYWCTDQVIVQRCLSAKNMSHVKGGCILCG     36E 
 |        : :      :  :  : |  : |  |                    : : | :  :     |    : :  :  :       | :   :      :  :  | |
INS 4–44  WMRLLPLLALLALWGPDPAAAFVNQHLCGSHL – – VEALYLVCG
                                                       | | :  :   |  |     : :      |         |  :  : :  : : :    /              |        |    :  | : | 
SLC5A1  184–218                         LLAITALYTI T GGLAAVIYTDT LQTVIML – – VGSL IL               31E
SLC5A1   79–100                      IGS GHFVGLAGTGAASGIA IGG           35E
                                                               : |  :       :     |       |  :  |  :  : :    : |  : :  |
INS 56–84  REAEDLQVGQVELGGGPGAGS LQPLALEG 
                                            | :  |     |  |       |      : |       |  :  | 
SLC5A1   603–618  RRAYDLFCG – LEQHGAP                                          33E 
SLC5A1   166–184                A I FI NLAL–GLNLYLA I FLL                                    34E
                                                          |  :  | : |        |    |    :  |       |  :  :  | :      
INS 20–42    GPDPAAAFVNQHLCGSHLVEALYLV
                                            |  |   /  |  |  :  | :
SLC5A1  464–472              GPP IAAVFL           33E 327
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A ﬁ  nal test of the hypothesis is bioinformatic. 
All glucose transporters in all species should con-
tain insulin-like sequences in their transport cores 
that are very highly conserved compared to other 
regions of the transporters. One of the interesting 
questions that arises evolutionarily is therefore 
whether insulin evolved prior to glucose transport-
ers, parallel to them, or from some precursor of the 
glucose transporters. Currently available data do 
not permit this problem to be resolved. Determin-
ing the structural relationships of insulins and 
GLUT derived from a very wide range of organisms 
may therefore shed important light on the molecu-
lar origins of glucose regulation and, in turn, new 
targets for the development of novel therapeutic 
regimens for diabetes.
Clinical Implications
The presence of insulin-like sequences in the 
GLUT has several pratical implications for under-
standing the consequences of hyperglycemia in 
both type 1 and type 2 diabetes. Perhaps the most 
important follows from the possibility that the 
Table 13. Na+/Glucose low afﬁ  nity co transporter 2/Insulin similarities.
Table 14. Na+/Glucose low afﬁ  nity co transporter 3/Insulin similarities.
SLC5A2 276–317  WPALLLGLT IVSGWYWCSDQVIVQRCLAGKSLTHIKAGCILCG        45E 
                                             |        | |       |   : :        |         :          : :  | :  :     |    |   /  |      | :  |       : :  |  |
INS 4–43  WMRLLPLLALLALWGPDPAAAFVNQHLCGSHL –VEALYLVCG 
                                             |     |  : :    |      |  | |     :
SLC5A2  649–661  WARVVNLNALLMM       39E 
SLC5A2  76–97    IG SGHFVGLAGTGAASGLAVAG      39E 
                                            : | :      : :     |       | :  |  :    :    |  |  :     |
INS 63–84    VGQVELGGGPGAGSLQPLALEG 
SLC5A2  558–617  RLVFSLRHSKEEREDLDADEQQGS SLPVQNGCPESAMEMNEPQAPAPSLFRQCLLWFCGM   38E
                                            |    :  |         :  : :  : |    |  |  |  :  :    :     :            |        /       \     |  :  |         :   :            | : :  :  |  |          |  |  :  :
INS 46–102    RGFFYTPKTRREAEDLQVGQVELGGGPGAGSLQPLALEGSLQKR – – – GI VEQCCT S I C SL 
SLC5A2  621–631  GVGSPPPLTQE     35E 
                | :  |  |      |  | :    |
INS 73–83    GAGSLQPLALE 
SLC5A2  67–89    VGASLFAS N IGSGHFVGLAGTGA    35E 
                                            |  |         \  : :  :     |  :  |   :        | |     :  | :
INS 63–85    VGQVELGGGPGAGSLQPLALEGS 
SLC5A4 276–317  WPG I IFGMP ITALWYWCTNQVIVQRCLCGKDMSHVKAACIMC         54E
                                             |        : :      :    :    |  |  |         :          : : |  :  :    |  |  |        :        | :  |        : :  | 
INS 4–43  WMRLLPLLALLALWGPDPAAAFVNQHLCGSHL – – VEALYLVC 
                                                    |  |         | : : |     | :
SLC5A4 140–151          RLQVYLSILSLF        26E 
SLC5A4 464–477    GPP I AAVFVLA I FC       42E
                                            |  |       |  |  :  | |           : |
INS 17–31    GPDPAAAFVNQHLC 
SLC5A4 133–143 KKRFGGERLQV     27E
                              |     |      :  |    |  |  |
INS 53–63    KTRREAEDLQV
SLC5A4    599–621             LKKAYDLFCGLQKG – – – – PKLTKEEEE  32E 
                                            |    :  |   \   |  :  |  |    :  :  |            |  |        : |     | :
INS 35–60 LVEALYLVCG– ERG FFYTPKTRREAED 328
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Table 15. Shared regions of homology between GLUT 1 and GLUT 4 and INSULIN, color coded as the key to 
Figure 1.
GLUT 1 56–93  I LPT–T LTTLW SLS – VA I FSVGG M I GSFSVGLFV NRFGRR WHITE
           : | |      : |    : |  |  :    :     : | : |   /          :    | |  :   |    : :            |    |
INSULIN 7–46  LLPLLALLALWGPDPAAAFV NQH LCGSHLVEALYLVCG ER 
   :  |       : |   : |  |  :    :     : |  : |   \         :       |  : | :    : :           |    :
GLUT 4 90–109        IPPG– TLTTL WALS – VA I FSVGG M I SSF L IG I ISQWLGRK 
GLUT 4 153–180  SGLVPMYVGE I APTHLRGALGTLNQLAI YELLOW
                        :    |  |  : :   | |   |  : | :    | | :
INSULIN 56–82  REAEDLQVGQVELGGGPGA–GSLQ PLAL
            :    |  | : |  :      :       | |    | :  | :   |  : :
GLUT 1 137–164   TGFVPMYVGEVSPTAFRGALGTLHQLG I
    |        : |     | |    |
GLUT 1 181–190            GN–KDL WPLLL
GLUT 4 307–330  FYYSTS I FETAGVGQPAYAT IGAG PURPLE
                      | : |  :            \  |  :       |    :     : : : |  :  |
INSULIN 47–71  FFYTPKTRREAEDLQVGQVELGGG
                                    | :  |  :           /   |  :     : |         :  : : |       |
GLUT 1 291–315      FYYSTS I FEKAGVQQPVYATIGSG
INSULIN 18–44  GPDPAAAFVNQHLCGSHLVEALY LVCG RED
   | |     |         | :        |      : :           |    :    |    |
GLUT 4 398–424  GPGPIPW FIVAELF SQGPRPAAMAVAG
             : : |   |           | |    |  |  |      |
INSULIN 10–26      LLALLA LWGPDPAAAFV
 : :  |   |   \      | |     |  | |  :   |
GLUT 1 390–406  I VAELFAQGPRPAA I AV 
GLUT 4 273–286       LSLLQL  LGSR THR TURQUOISE
       | :    |     |   |  |     : : |
INSULIN 79–92         L QPLALEGSLQKR
     : :    |    |       |         |
GLUT 1 258–269      VT I LELFRS PAYR 
 GLUT 4 124–147  SLMGLANAAASYEML ILGRF LIGA  GREEN
     : |     |     /   |  |  |      : :    :   |       | :    |
  INS 15–38          ALWGPDPAAAFVNQHLCGSHLVEA 
  : |     |    :      :      : :   :    |       : : 
  GLUT 1 112–135   VLMGF SKLGKSFEM LI LGRF I I GV 329
Evolution of glucose transporters (GLUT) with implications for diabetes
Evolutionary Bioinformatics 2007: 3
insulin-like regions of GLUT glycate rapidly under 
hyperglycemic conditions. (Parenthetically, one 
might expect fructose glycation of GLUT 2 and 
GLUT 5 since these transport fructose as well as 
glucose [Schalkwijk, Stehouwer and van Hinsbergh, 
2004]). The glycation of binding sites for glucose 
transport would be predicted to interfere with glu-
cose transport by blocking the transport cores, thus 
exacerbating hyperglycemia. The greater the 
hyperglycemia, the greater the glycation, and the 
greater the percentage of GLUTs that would mal-
function. A positive feedback system would be set 
up that is self-destructive. The paradoxical result 
would be that the greater the hyperglycemia, the 
less glucose would be transported into cells. Cells, 
starved for a ready energy source, would have to 
metabolize protein, resulting in the ketosis associ-
ated with hyperglycemia. In children with diabetes, 
the result of such refractory glucose transport 
would be to inhibit critical developmental pro-
cesses that are glucose-dependent, such as bone 
growth (Mobasheri et al. 2002) and insulin-
dependent neuron growth (Whitmer, 2007), result-
ing in long term deﬁ  cits.
Two additional effects of hyperglycemic glyca-
tion might also result. First, if GLUT and sodium-
dependent glucose transporters are critical sensors 
for blood glucose concentration as is currently 
thought (Freeman et al. 2006; Uldry and Thorens, 
2004; Bogacka et al. 2004; Ferber et al. 1994; 
Leloup et al. 1994), then glucose regulation might 
be impaired because glucose sensing would be 
impaired not only in somatic cells but in the brain. 
Various types of neurons act as glucose sensors in 
the brain, helping to regulate glucose homeostasis 
(Parton et al. 2007), so that blocking glucose trans-
port in neurons would also exacerbate glucose 
disregulation. Secondly, if the same rapid glycation 
reaction occurs on insulin-like regions of the insu-
lin receptor (Root-Bernstein, 2002; Root-Bernstein, 
2005), then insulin activation of its receptor may 
be impaired, resulting in the insulin-resistance that 
is associated with diabetes. The combination of 
these two malfunctions would be an inability for 
the glucose-regulatory system to sense or respond 
to its normal regulatory cues.
Understanding the evolutionary structure-function 
relationship of insulin and GLUT may also provide 
hints about a novel therapeutic approach to treating 
auto-glycation. Since GLUT transport dehydro-
ascorbate (DHA), it is possible that serum ascor-
bate or DHA levels may be a critical factor in 
preventing (the assumed) GLUT auto-glycation. 
In essence, higher levels of DHA (which can be 
generated by higher levels of dietary or transfused 
ascorbate or DHA itself), will compete with glu-
cose for the GLUT transport sites; DHA competi-
tion for glucose binding sites on insulin-like 
regions of GLUT may decrease auto-glycation of 
GLUT (as well as on insulin and the insulin 
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receptor), thereby helping to prevent some of the 
deleterious effects of hyperglycemia. This possibil-
ity is also testable by determining rates of auto-
glycation of insulin and or insulin-like regions in 
GLUT in the presence and absence of various 
concentrations of DHA and ascorbic acid. The 
likelihood that this approach will be successful is 
indicated by a report by Abdel-Wahab et al. (2002) 
that ascorbic acid supplementation decreases insu-
lin glycation in obese hyperglycemic mice. Clearly, 
these results need to be extended to determine rates 
of glycation of GLUT and insulin receptors in the 
presence of ascorbate and DHA.
Finally, the same factors just discussed in terms 
of diabetes may have relevance for understanding 
some aspects of normal aging as well. The rate of 
protein turn-over, particularly of GLUT, is well-
documented to decrease with increasing age 
(Mooradian and Shah, 1997). This means that as 
a person ages, GLUT will be exposed for longer 
times to normal glucose serum concentrations. In 
addition, ascorbate (and thus DHA) deﬁ  ciency 
increases with age (Junquiera et al. 2004) The 
result of prolonged exposure of GLUT to glucose 
and decreased antioxidant concentrations would 
be increased GLUT glycation, resulting in body-
wide decreased sugar transport and decreased 
glucose sensitivity. These are early symptoms of 
metabolic syndrome, a pre-diabetic state also 
known to increase in prevalence with aging 
(Rodriguez et al. 2007; Yaffe, 2007). Indeed, the 
formation of advanced glycation endproducts is a 
major problem not only in diabetes, but in demen-
tias as well (Vlassara and Palace, 2002; Baynes, 
2001). Perhaps these syndromes, too, might be 
responsive to increased DHA intake.
Summary
In sum, I have proposed an evolutionary basis for 
GLUT structure based on a modular units originat-
ing in insulin-glucose binding. The model that 
results suggests various experimentally testable 
implications including a mechanism for GLUT 
transport of glucose via a series of insulin-like 
sequences that form the GLUT transport cores. The 
proposed structure also suggests the possibility that 
GLUT are auto-glycated under hyperglycemic 
conditions, resulting in defective glucose transport 
and regulation, and it proposes that dehydroascor-
bate (DHA) may prevent such auto-glycation by 
direct competition for the glucose binding sites. 
Thus, a simple modular approach to GLUT evolu-
tion based on small molecule complementarity may 
provide basic insights into the structure and func-
tion of a major protein and its modiﬁ  cations in 
disease states.
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